Nectar lifesciences Limited has announced the launch of its second 100-day special outreach initiative titled 'Saksham Niveshak' from April 01, 2026, to July 09, 2026. The campaign has been initiated pursuant to communication from the Investor Education and Protection Fund Authority, Ministry of Corporate Affairs, dated March 27, 2026.

Campaign Objectives and Benefits

The Saksham Niveshak campaign serves dual purposes for shareholders, focusing on critical administrative updates and financial recoveries. The initiative aims to assist investors in updating their KYC details, including bank account mandates, nominee registration, and contact information such as email addresses, mobile numbers, and postal addresses. Additionally, the campaign enables shareholders to claim their unpaid or unclaimed dividends, specifically targeting Final Dividend 2018-19 and 2019-20.

Shareholder Action Requirements

The company emphasizes the importance of maintaining updated records with the Registrar and Share Transfer Agent or Depository Participants. Since dividends are payable only through electronic mode, amounts will be credited to shareholders' bank accounts only after required information and documents are properly updated. Key details that require updating include:

• PAN details
• Nomination information
• Contact information including postal address and mobile number
• Bank account details
• Specimen signature

Contact Information and Support

Shareholders seeking to participate in the campaign can reach out through multiple channels. The company has provided comprehensive contact details for both its Registrar and Share Transfer Agent, as well as direct company contacts.

Regulatory Compliance and Urgency

The campaign carries significant regulatory implications for shareholders. According to applicable provisions, dividends that remain unclaimed or unpaid for seven consecutive years, along with corresponding shares, are liable to be transferred to the IEPF Authority. The company has made unclaimed dividend details for Final Dividend 2018-19 and 2019-20 available on its website at www.neclife.com/about-3-12 .

Shareholders with incomplete KYC records are advised to approach their Depository Participant for shares held in electronic mode, or contact the RTA or company directly for shares held in physical mode. The company urges all investors to take prompt action during the campaign period to safeguard their entitlements and avoid the complexities of claiming dividends and shares from the IEPF Authority.

Nectar Lifesciences Limited has submitted its quarterly dematerialization compliance certificate to stock exchanges for the quarter ended March 31, 2026. The pharmaceutical company filed the mandatory documentation with both the National Stock Exchange of India Limited and BSE Limited on April 06, 2026.

Regulatory Compliance Filing

The certificate was submitted pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Sanjaymohan Singh Rawat signed and submitted the documentation to fulfill the quarterly reporting requirement.

Certificate Confirmation

KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate dated April 06, 2026. The certificate confirms that securities received from depository participants for dematerialization during the quarter were processed according to regulatory requirements.

The registrar certified that:

• Securities received for dematerialization were confirmed to depositories within prescribed timelines
• Accepted security certificates were properly mutilated and cancelled
• Depository names were substituted in the register of members as registered owners
• Required certificates were submitted to depositories and stock exchanges

Documentation Process

Vice President Dnyanesh Gharote signed the certificate on behalf of KFin Technologies Limited from their operations center in Hyderabad. The documentation ensures compliance with SEBI regulations governing the dematerialization process for listed securities.

This quarterly filing represents part of the ongoing regulatory compliance requirements for listed companies to maintain transparency in their share transfer and dematerialization activities with stock market regulators.